News of Note—Boehringer expands China CDMO operation

news of note
(Pixabay)

> Germany's Boehringer Ingelheim is adding a bioreactor to its CDMO operation in China in anticipation of producing a monoclonal antibody at the facility this year. Release 

> The National Institute for Innovation in Manufacturing Biopharmaceuticals (NIIMBL) is providing $32 million in grants for a long list of projects designed to improve biopharmaceutical manufacturing technology. Release

> MedPharm is investing $4 million to triple the size of its facility in Durham, North Carolina, for formulation development and performance testing of topical and transdermal medicines as well as increasing its LC/MS capacity and the automation of sample handling. Release

> The European Medicines Agency has reinstated the GMP manufacturing certificate to the Bristol Laboratories plant in Luton after a follow-up inspection found it had resolved issues raised in 2017. Report